Vaginal Yeast Infections

References

Citations

1. Bauters TGM, et al. (2002). Prevalence of vulvovaginal candidiasis and susceptibility to fluconazole in women. American Journal of Obstetrics and Gynecology, 187(3): 569–574.

2. Ferris DG, et al. (2002). Over-the-counter antifungal drug misuse associated with patient-diagnosed vulvovaginal candidiasis. Obstetrics and Gynecology, 99(3): 419–425.

3. Kessel KV, et al. (2003). Common complementary and alternative therapies for yeast vaginitis and bacterial vaginosis: A systematic review. Obstetrical and Gynecological Survey, 58(5): 351–358.

4. Centers for Disease Control and Prevention (2006). Vulvovaginal candidiasis section of Sexually transmitted diseases treatment guidelines, 2006. MMWR, 55(RR-11): 54–56.

5. Eschenbach DA (2003). Vaginitis section of Pelvic infections and sexually transmitted diseases. In JR Scott et al., eds., Danforth's Obstetrics and Gynecology, 9th ed., pp. 585–589. Philadelphia: Lippincott Williams and Wilkins.

6. Pirotta M, et al. (2004). Effect of lactobacillus in preventing post-antibiotic vulvovaginal candidiasis: A randomised controlled trial. BMJ, 329(7465): 548.

7. Spence D (2007). Candidiasis (vulvovaginal), search date October 2006. Online version of BMJ Clinical Evidence. Also available online: http://www.clinicalevidence.com.

Go to previous section	Go to top of page	Go to next section
Author:	Sandy Jocoy, RN	Last Updated: June 17, 2008
Medical Review:	Joy Melnikow, MD, MPH - Family Medicine Deborah A. Penava, BA, MD, FRCSC, MPH - Obstetrics and Gynecology
© 1995-2009 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.